SARAH MEIER: Open Payments
NPI 1710463625 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$458 in 34 payments from 7 companies in 2025. Trend: 2023 $442 · 2024 $525 · 2025 $458
Food & beverage: $458
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 22 | $185 |
| Novartis Pharmaceuticals Corporation | 4 | $131 |
| Astellas Pharma US Inc | 4 | $69 |
| Janssen Biotech, Inc. | 1 | $22 |
| TOLMAR, INC. | 1 | $17 |
| pharmaand GmbH | 1 | $17 |
| Janssen Scientific Affairs, LLC | 1 | $16 |
Products named: ORGOVYX, PLUVICTO, ERLEADA, Xtandi, Padcev, RUBRACA.
Industry payments across NE — which companies pay providers there.
